Biosimilars: A New Generation of Biologics - Image 1

£88.19

Springer Biosimilars: A New Generation of Biologics

Name: Biosimilars: A New Generation of Biologics
Brand: Springer
Price: 88.19 GBP
Availability: InStock

Pharmacy - Dispensing

This is the most expensive it has ever been. Walk away.

£88 today · previous high £88 · all-time low £88

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 71 days · 71 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 71 days • 1 price levels

Days at Price

Price Analysis

Most common price: £88 (71 days, 100.0%)

Price range: £88 - £88

Price levels: 1 different prices over 71 days

Description

Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 2817805143
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 14 December 2014
Listed Since: 04 December 2014

Barcode

No barcode data available

Springer Biosimilars: A New Generation of Biologics

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars: A New Generation of Biologics

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

ASHP Biosimilars and Biologics - Implementation and Monitoring

Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Biosimilars and Interchangeable Biologics: Strategic Elements

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

dorosz guide pratique des medicaments 2021, 40e ed

Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead

Dorosz Guide pratique des médicaments 2025, 44e éd.

Dorosz guide pratique des medicaments 2023, 42e ed

Biopharmaceuticals: Biochemistry and Biotechnology

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals